Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study
I-Chieh Mao,1 Ching-Yeh Lin,2 Chia-Lin Wu,3,4 Chew-Teng Kor,5,6 Chia-Chu Chang3,7–9 1Division of Critical Care, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan; 2Division of Hematology and Oncology, Department of Internal Medicine, Changhua Christia...
Main Authors: | Mao IC, Lin CY, Wu CL, Kor CT, Chang CC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-08-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/hydroxychloroquine-and-risk-of-development-of-cancers-a-nationwide-pop-peer-reviewed-article-TCRM |
Similar Items
-
Progress in the risk assessment of hydroxychloroquine in frail elderly people
by: Alberto Castagna, et al.
Published: (2021-03-01) -
Protective effect of hydroxychloroquine on rheumatoid arthritis‐associated atherosclerosis
by: Na Shi, et al.
Published: (2019-06-01) -
Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study
by: Chien-Hsien Lo, et al.
Published: (2021-04-01) -
The place of hydroxychloroquine in modern dermatology
by: Aleksandra Dańczak-Pazdrowska, et al.
Published: (2021-08-01) -
Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis
by: Yi-Chia Lin, et al.
Published: (2017-05-01)